SCA
IMGN

SAC Capital Advisors’s Immunogen Inc IMGN Stock Holding History

SAC Capital Advisors’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-10,452
Closed -$178K – 2024
2013
Q3 		$178K Buy
+10,452
New +$184K ﹤0.01% 1623

Other funds holding IMGN

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SAC Capital Advisors's IMGN Position: Q4 2013 in Review

SAC Capital Advisors sold out of Immunogen Inc (IMGN) in Q4 2013, closing a stake of 10,452 shares — an estimated $178K sold.

SAC Capital Advisors first reported a position in IMGN in Q3 2013 and held it in 1 quarter. The position peaked at $178K in Q3 2013. 135 funds tracked by Wall St. Rank hold IMGN as of Q4 2013.

  • SAC Capital Advisors reported no remaining Immunogen Inc position as of Q4 2013 after selling out during the quarter.
  • SAC Capital Advisors sold 10,452 Immunogen Inc shares in Q4 2013, an estimated $178K.
  • SAC Capital Advisors first reported a position in Immunogen Inc in Q3 2013 and held it in 1 quarter.
  • SAC Capital Advisors's Immunogen Inc position peaked at $178K in Q3 2013.
  • 135 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2013.

Based on SAC Capital Advisors's 13F filing for Q4 2013, filed 14 Feb 2014.